rs17651157

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001281740.3(FHOD3):​c.511+14946T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0679 in 152,294 control chromosomes in the GnomAD database, including 560 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.068 ( 560 hom., cov: 32)

Consequence

FHOD3
NM_001281740.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.241

Publications

8 publications found
Variant links:
Genes affected
FHOD3 (HGNC:26178): (formin homology 2 domain containing 3) The protein encoded by this gene is a member of the diaphanous-related formins (DRF), and contains multiple domains, including GBD (GTPase-binding domain), DID (diaphanous inhibitory domain), FH1 (formin homology 1), FH2 (formin homology 2), and DAD (diaphanous auto-regulatory domain) domains. This protein is thought to play a role in actin filament polymerization in cardiomyocytes. Mutations in this gene have been associated with dilated cardiomyopathy (DCM), characterized by dilation of the ventricular chamber, leading to impairment of systolic pump function and subsequent heart failure. Increased levels of the protein encoded by this gene have been observed in individuals with hypertrophic cardiomyopathy (HCM). Alternative splicing results in multiple transcript variants encoding different isoforms. A muscle-specific isoform has been shown to possess a casein kinase 2 (CK2) phosphorylation site at the C-terminal end of the FH2 domain. Phosphorylation of this site alters its interaction with sequestosome 1 (SQSTM1), and targets this isoform to myofibrils, while other isoforms form cytoplasmic aggregates. [provided by RefSeq, Aug 2015]
FHOD3 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, ClinGen
  • cardiomyopathy, familial hypertrophic, 28
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.212 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001281740.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FHOD3
NM_001281740.3
MANE Select
c.511+14946T>C
intron
N/ANP_001268669.1Q2V2M9-4
FHOD3
NM_025135.5
c.511+14946T>C
intron
N/ANP_079411.2
FHOD3
NM_001281739.3
c.511+14946T>C
intron
N/ANP_001268668.1Q2V2M9-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FHOD3
ENST00000590592.6
TSL:1 MANE Select
c.511+14946T>C
intron
N/AENSP00000466937.1Q2V2M9-4
FHOD3
ENST00000257209.8
TSL:1
c.511+14946T>C
intron
N/AENSP00000257209.3Q2V2M9-3
FHOD3
ENST00000359247.8
TSL:1
c.511+14946T>C
intron
N/AENSP00000352186.3Q2V2M9-1

Frequencies

GnomAD3 genomes
AF:
0.0679
AC:
10338
AN:
152176
Hom.:
560
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0305
Gnomad AMI
AF:
0.0504
Gnomad AMR
AF:
0.145
Gnomad ASJ
AF:
0.0435
Gnomad EAS
AF:
0.0501
Gnomad SAS
AF:
0.224
Gnomad FIN
AF:
0.0387
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.0699
Gnomad OTH
AF:
0.0664
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0679
AC:
10344
AN:
152294
Hom.:
560
Cov.:
32
AF XY:
0.0704
AC XY:
5240
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.0305
AC:
1268
AN:
41558
American (AMR)
AF:
0.145
AC:
2213
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0435
AC:
151
AN:
3470
East Asian (EAS)
AF:
0.0504
AC:
261
AN:
5180
South Asian (SAS)
AF:
0.223
AC:
1076
AN:
4822
European-Finnish (FIN)
AF:
0.0387
AC:
411
AN:
10620
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.0699
AC:
4758
AN:
68028
Other (OTH)
AF:
0.0686
AC:
145
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
472
944
1417
1889
2361
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0680
Hom.:
1280
Bravo
AF:
0.0702
Asia WGS
AF:
0.128
AC:
447
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
4.4
DANN
Benign
0.38
PhyloP100
0.24
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17651157; hg19: chr18-34107452; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.